Literature DB >> 30345645

Successful treatment outcomes in pregnant patients with ANCA-associated vasculitides: A systematic review of literature.

Pawan Singh1, Aadhaar Dhooria2, Manish Rathi3, Ritesh Agarwal1, Kusum Sharma4, Varun Dhir2, Ritambhra Nada5, Ranjana Minz6, Vanita Suri7, Sanjay Jain2, Aman Sharma2.   

Abstract

AIM: Antineutrophil cytoplasmic antibody-associated vasculitides (AAV) are a group of small vessel vasculitis with systemic presentations and considerable morbidity and mortality. Pregnancy in these patients poses a significant therapeutic challenge. There is limited published literature regarding pregnancy in AAV.
METHODS: Two cases of successful pregnancy outcomes in patients with active AAV are described. A systematic review was conducted on the lines of the PRISMA statement for conducting systemic reviews: PubMed (inception of PubMed until 30 April 2017, English language only) and EmBase databases were searched using the following terms: 'pregnancy' AND 'ANCA associated vasculitis' OR 'granulomatosis with polyangiitis' OR 'eosinophilic granulomatosis with polyangiitis' OR 'microscopic polyangiitis' OR 'Churg-Strauss syndrome' OR 'Wegener's granulomatosis'.
RESULTS: One hundred and thirty-seven pregnancies were documented in 110 patients of AAV. Vasculitis diagnosis was made before pregnancy in 69, during pregnancy in 32 and after pregnancy in 9 patients. Mean age at the time of pregnancy was 29.3 ± 5.3 years. There were 91 term pregnancies, 28 were preterm pregnancies, 15 abortions and 3 still births; 78 had normal delivery and 26 had caesarian section.
CONCLUSION: Successful pregnancies have been reported in AAV patients.
© 2018 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  ANCA associated vasculitis; Churg-Strauss syndrome; GPA; Wegener's granulomatosis; cyclophosphamide; pregnancy outcomes; pregnancy treatment; rituximab

Mesh:

Substances:

Year:  2018        PMID: 30345645     DOI: 10.1111/1756-185X.13342

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  3 in total

Review 1.  [New aspects of rare rheumatic diseases during pregnancy].

Authors:  Jörg Henes; Ann-Christin Pecher
Journal:  Z Rheumatol       Date:  2021-09-17       Impact factor: 1.372

Review 2.  Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives.

Authors:  Ann-Christin Pecher; Melanie Henes; Joerg Christoph Henes
Journal:  Arch Gynecol Obstet       Date:  2022-09-14       Impact factor: 2.493

Review 3.  Pregnancy Outcomes in Systemic Vasculitides.

Authors:  Carolyn Ross; Rohan D'Souza; Christian Pagnoux
Journal:  Curr Rheumatol Rep       Date:  2020-08-26       Impact factor: 4.592

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.